Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | ESR1 | P03372 | 6/20 | 0.38 |
| ▸ | ESR2 | Q92731 | 6/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TYR | P14679 | 1/20 | 0.35 |
| ▸ | ABL1 | P00519 | 1/20 | 0.35 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.35 |
| ▸ | BCR | P11274 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.34 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5030675 | 0.84 | CYP1A2 (0.44) | CYP1A2ESR1ESR2CYP3A4HSD17B10 | |
| SCHEMBL8777379 | 0.84 | CYP1A2 (0.44) | CYP1A2ESR1ESR2CYP3A4HSD17B10 | |
| SCHEMBL9236158 | 0.77 | CYP2A6 (0.44) | CYP1A2HSD17B10TDP1ALOX15MEN1 | |
| SCHEMBL5034850 | 0.77 | ESR1 (0.37) | CYP1A2ESR1ESR2CYP3A4HSD17B10 | |
| SCHEMBL5028372 | 0.77 | CYP1A2 (0.39) | CYP1A2ESR1ESR2CYP3A4HSD17B10 | |
| SCHEMBL42059 | 0.73 | CYP1A2 (0.37) | CYP1A2ESR1ESR2CYP3A4HSD17B10 | |
| SCHEMBL2776537 | 0.73 | CYP1A2 (0.37) | CYP1A2ESR1ESR2CYP3A4HSD17B10 | |
| SCHEMBL1128294 | 0.73 | CYP1A2 (0.43) | CYP1A2ESR1ESR2CYP3A4HSD17B10 | |
| SCHEMBL6631385 | 0.71 | ALDH1A1 (0.47) | CYP1A2HSD17B10TDP1TSHRCYP2C9 | |
| SCHEMBL22127724 | 0.71 | CYP1A2 (0.41) | CYP1A2ESR1ESR2CYP3A4HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4523958-A | MILLING COPPER PHTHALOCYANINE AND IRON HEXACYANOFERRATE PIGMENTS | BASF AKTIENGESELLSCHAFT (DE) | 1985-06-18 | — | — | US | claimed |
| EP-0090285-B1 | PIGMENT PREPARATIONS AND THEIR USE IN PIGMENTING HELIOGRAPHIC AND LAC COLOURS | BASF Aktiengesellschaft (DE) | 1985-01-16 | — | — | EP | claimed |
| US-4490176-A | PRINTING INKS, PAINTS; PIGMENT, ALKYLBENZENE SULFONIC ACID, HYDROXYNAPHTHALENE | BASF AKTIENGESELLSCHAFT (DE) | 1984-12-25 | — | — | US | claimed |
| EP-0076995-B1 | LIQUID STABLE PREPARATIONS AND THEIR USE | BASF Aktiengesellschaft (DE) | 1984-07-11 | — | — | EP | claimed |
| EP-0043932-B1 | LIQUID, STABLE PREPARATIONS OF PHTHALOCYANINE PIGMENTS OR INDANTHRON AND THEIR USE | BASF Aktiengesellschaft (DE) | 1984-04-18 | — | — | EP | claimed |
| EP-0090285-A2 | Pigment preparations and their use in pigmenting heliographic and lac colours | BASF Aktiengesellschaft (DE) | 1983-10-05 | — | — | EP | claimed |
| EP-0076995-A1 | Liquid stable preparations and their use | BASF Aktiengesellschaft (DE) | 1983-04-20 | — | — | EP | claimed |
| US-4350534-A | Fluid, stable formulations of copper phthalocyanine or indanthrone | BASF AKTIENGESELLSCHAFT (DE) | 1982-09-21 | — | — | US | claimed |
| EP-0043932-A1 | Liquid, stable preparations of phthalocyanine pigments or indanthron and their use | BASF Aktiengesellschaft (DE) | 1982-01-20 | — | — | EP | claimed |
| CN-108368237-B | Epoxy resin, method for producing epoxy resin, curable resin composition, and cured product thereof | DIC株式会社 | 2021-04-02 | — | — | CN | disclosed |
| CN-104684902-A | Epoxy compound and method for production thereof, and epoxy resin composition and cured product thereof | DAINIPPON INK & CHEMICALS | 2015-06-03 | — | — | CN | disclosed |
| US-8735416-B2 | Antiviral therapies | TECHNISCHE UNIVERSITAET CAROLO-WILHELMINA ZU BRAUNSCHWEIG (DE) | 2014-05-27 | — | — | US | disclosed |
| US-20140113923-A1 | NOVEL ANTIVIRAL THERAPIES | TECHNISCHE UNIVERSITAET CAROLO-WILHELMINA ZU BRAUNSCHWEIG (DE) | 2014-04-24 | — | — | US | disclosed |
| EP-2484360-A1 | Phenylboronic acid compounds as antiviral agents | K.U. Leuven Research and Development (BE) | 2012-08-08 | — | — | EP | disclosed |
| EP-0076995-B1 | LIQUID STABLE PREPARATIONS AND THEIR USE | BASF Aktiengesellschaft (DE) | 1984-07-11 | — | — | EP | disclosed |
| EP-0043932-B1 | LIQUID, STABLE PREPARATIONS OF PHTHALOCYANINE PIGMENTS OR INDANTHRON AND THEIR USE | BASF Aktiengesellschaft (DE) | 1984-04-18 | — | — | EP | disclosed |
| EP-0090285-A2 | Pigment preparations and their use in pigmenting heliographic and lac colours | BASF Aktiengesellschaft (DE) | 1983-10-05 | — | — | EP | disclosed |
| EP-0076995-A1 | Liquid stable preparations and their use | BASF Aktiengesellschaft (DE) | 1983-04-20 | — | — | EP | disclosed |
| US-4350534-A | Fluid, stable formulations of copper phthalocyanine or indanthrone | BASF AKTIENGESELLSCHAFT (DE) | 1982-09-21 | — | — | US | disclosed |
| EP-0043932-A1 | Liquid, stable preparations of phthalocyanine pigments or indanthron and their use | BASF Aktiengesellschaft (DE) | 1982-01-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140113923-A1 | NOVEL ANTIVIRAL THERAPIES | HAVCR2, LGALS3BP, LGALS4 | CYP1A2 1548/4885ESR1 4411/4885ESR2 3862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.